| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
1 on Mesangial Cells by Overexpression of Smad7



*Departments of Medicine and
Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina; and
Medical Specialty Service, Ralph H. Johnson VA Medical Center, Charleston, South Carolina.
Correspondence to: Dr. Richard V. Paul, Division of Nephrology, Department of Medicine, Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC 29425. Phone: 803-792-4123; Fax: 803-792-8399; E-mail: paulr{at}musc.edu
ABSTRACT. Smad7, a protein induced by transforming growth factor
1 (TGF-
1) in many target cells, inhibits TGF-
1 signal transduction and is thought to mediate an intracellular negative feedback response that limits TGF-
1 effects. It is possible that overexpression of Smad7 could block specified effects of TGF-
1 on mesangial cells, a TGF-
target in glomerular disease. Smad7 mRNA was induced by TGF-
1 within 1 h in a concentration-dependent manner in a transformed mouse mesangial cell (MMC) line. Uptake of 14C-spermidine from the medium by MMC and the transcriptional activity of a segment of the human collagen pro-
2 type 1 chain (COL1A2) promoter fused to a luciferase reporter gene were used as indices of TGF-
1. Treatment with TGF-
1 increased 14C-spermidine uptake rate in a time-, concentration-, and temperature-dependent manner. For example, exposure to 1 ng/ml TGF-
1 for 15 h increased uptake approximately twofold, a response that was attenuated by cycloheximide. Transfection of Smad7 expression vector into MMC abrogated both TGF-
1-dependent stimulation of spermidine uptake and COL1A2 promoter activity. It is concluded that: (1) TGF-
1 induces Smad7 in MMC; (2) 14C-spermidine uptake is a convenient quantitative index of TGF-
1 effect in these cells; and (3) overexpression of Smad7 is a highly effective method of blocking at least some mesangial cell effects of TGF-
1 that may warrant evaluation in vivo in experimental glomerular disease.
This article has been cited by other articles:
![]() |
M. Ruiz-Ortega, M. Ruperez, V. Esteban, J. Rodriguez-Vita, E. Sanchez-Lopez, G. Carvajal, and J. Egido Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases Nephrol. Dial. Transplant., January 1, 2006; 21(1): 16 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rodriguez-Vita, E. Sanchez-Lopez, V. Esteban, M. Ruperez, J. Egido, and M. Ruiz-Ortega Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-{beta}-Independent Mechanism Circulation, May 17, 2005; 111(19): 2509 - 2517. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Satoguina, E. Weyand, J. Larbi, and A. Hoerauf T Regulatory-1 Cells Induce IgG4 Production by B Cells: Role of IL-10 J. Immunol., April 15, 2005; 174(8): 4718 - 4726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Hou, W. Wang, X. R. Huang, P. Fu, T.-H. Chen, D. Sheikh-Hamad, and H. Y. Lan Ultrasound-Microbubble-Mediated Gene Transfer of Inducible Smad7 Blocks Transforming Growth Factor-{beta} Signaling and Fibrosis in Rat Remnant Kidney Am. J. Pathol., March 1, 2005; 166(3): 761 - 771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vrljicak, D. Myburgh, A. K. Ryan, M. A. van Rooijen, C. L. Mummery, and I. R. Gupta Smad expression during kidney development Am J Physiol Renal Physiol, April 1, 2004; 286(4): F625 - F633. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Lan, W. Mu, N. Tomita, X. R. Huang, J. H. Li, H.-J. Zhu, R. Morishita, and R. J. Johnson Inhibition of Renal Fibrosis by Gene Transfer of Inducible Smad7 Using Ultrasound-Microbubble System in Rat UUO Model J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1535 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Mason and N. A. Wahab Extracellular Matrix Metabolism in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1358 - 1373. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kanasaki, D. Koya, T. Sugimoto, M. Isono, A. Kashiwagi, and M. Haneda N-Acetyl-Seryl-Aspartyl-Lysyl-Proline Inhibits TGF-{beta}-Mediated Plasminogen Activator Inhibitor-1 Expression via Inhibition of Smad Pathway in Human Mesangial Cells J. Am. Soc. Nephrol., April 1, 2003; 14(4): 863 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Schnaper, T. Hayashida, S. C. Hubchak, and A.-C. Poncelet TGF-beta signal transduction and mesangial cell fibrogenesis Am J Physiol Renal Physiol, February 1, 2003; 284(2): F243 - F252. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Sharpe and B. M. Hendry Signaling: Focus on Rho in Renal Disease J. Am. Soc. Nephrol., January 1, 2003; 14(1): 261 - 264. [Full Text] [PDF] |
||||
![]() |
H. W. Schnaper, T. Hayashida, and A.-C. Poncelet It's a Smad World: Regulation of TGF-{beta} Signaling in the Kidney J. Am. Soc. Nephrol., April 1, 2002; 13(4): 1126 - 1128. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673